ENSTILAR

This brand name is authorized in Austria, Australia, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Lithuania, Malta, Netherlands, New Zealand, Poland, United Kingdom, United States

Active ingredients

The drug ENSTILAR contains a combination of these active pharmaceutical ingredients (APIs):

1 Calcipotriol
UNII S7499TYY6G - CALCIPOTRIENE MONOHYDRATE

Calcipotriol is a derivative of vitamin D for topical use on psoriasis. It probably works by suppressing keratinization. Advantage of substance or absence of odor and non-coloring of clothing.

Read about Calcipotriol
2 Betamethasone
UNII 826Y60901U - BETAMETHASONE DIPROPIONATE

Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties.

Read about Betamethasone

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ENSTILAR Foam FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
D05AX52 Calcipotriol, combinations D Dermatologicals → D05 Antipsoriatics → D05A Antipsoriatics for topical use → D05AX Other antipsoriatics for topical use
Discover more medicines within D05AX52

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 11091R
Country: CA Health Products and Food Branch Identifier(s): 02457393
Country: EE Ravimiamet Identifier(s): 1680050, 1680061
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 80896
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 561259, 579406
Country: FR Base de données publique des médicaments Identifier(s): 67347855
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 326154, 351733, 380788, 381332, 387248
Country: HK Department of Health Drug Office Identifier(s): 66143
Country: IE Health Products Regulatory Authority Identifier(s): 43072, 43073
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 8625
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1075861, 1080064
Country: MT Medicines Authority Identifier(s): MA024/01101
Country: NL Z-Index G-Standaard, PRK Identifier(s): 133329
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 18324
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100339770
Country: US FDA, National Drug Code Identifier(s): 50222-302

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.